Assessment of Cardiovascular Safety of Anti-Osteoporosis Drugs. (2020)

First Author: Fuggle NR
Attributed to:  Lifecourse Determinants of Bone and Joint Disease funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1007/s40265-020-01364-2

PubMed Identifier: 32725307

Publication URI: http://europepmc.org/abstract/MED/32725307

Type: Journal Article/Review

Volume: 80

Parent Publication: Drugs

Issue: 15

ISSN: 0012-6667